Plenary 1, Tuesday April 3, 2018;  2:00 pm - 4:10 pm

(PL 1) Consciousness and Psychedelics 

Robin Carhart Harris, Imperial College, London    

Jimo Borjigin, University of Michigan       

Anil K. Seth, University of Sussex 


Robin Carhart Harris, PhD

Head of Psychedelic Research,

Centre for Neuropsychopharmacology

Imperial College London





Dr. Harris is Head the Psychedelic Research Group at Imperial College London.

The focuses on using functional brain imaging to assess how psychedelic compounds work in the brain and also explores their therapeutic potential, with a particular focus on depression.


After an MA in Psychoanalysis at Brunel University, London, Carhart-Harris completed his PhD in psychopharmacology at the University of Bristol. In 2009, under the mentorship of Professor David Nutt, Carhart-Harris moved to Imperial College London to continue his fMRI research with the classic psychedelic drug psilocybin (magic mushrooms). 


Over the last four years Carhart-Harris and Nutt have built up a programme of research with psychedelics that includes fMR and MEG imaging with psilocybin, fMR imaging with MDMA and soon an MRC-sponsored clinical trial to assess the efficacy of psilocybin as a treatment for major depression.